BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 23443962)

  • 1. Lung cancer: how to face the revolution?
    Morère JF; Penault-Llorca F
    Target Oncol; 2013 Mar; 8(1):1-2. PubMed ID: 23443962
    [No Abstract]   [Full Text] [Related]  

  • 2. Molecular prognostication of non-small cell lung cancer.
    Tsao MS; Jablons DM
    Semin Thorac Cardiovasc Surg; 2013; 25(1):4-7. PubMed ID: 23800523
    [No Abstract]   [Full Text] [Related]  

  • 3. Non-small cell lung cancer: One size doesn't fit all.
    Leung L; Lam KC; Mok TS
    Asia Pac J Clin Oncol; 2012 Sep; 8(3):211-2. PubMed ID: 22913780
    [No Abstract]   [Full Text] [Related]  

  • 4. Advancing personalized cancer medicine in lung cancer.
    MacConaill LE
    Arch Pathol Lab Med; 2012 Oct; 136(10):1210-6. PubMed ID: 23020726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Personalized medicine for non-small-cell lung cancer: implications of recent advances in tissue acquisition for molecular and histologic testing.
    Moreira AL; Thornton RH
    Clin Lung Cancer; 2012 Sep; 13(5):334-9. PubMed ID: 22424871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating microRNAs: possible prediction biomarkers for personalized therapy of non-small-cell lung carcinoma.
    Gao W; Liu L; Lu X; Shu Y
    Clin Lung Cancer; 2011 Jan; 12(1):14-7. PubMed ID: 21273174
    [No Abstract]   [Full Text] [Related]  

  • 7. [Association of molecular biology of lung cancers and their metastasis and prognosis].
    Mao YS; Gao YN; He J
    Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):632-4. PubMed ID: 17236563
    [No Abstract]   [Full Text] [Related]  

  • 8. "Personalizing" therapy for non-small cell lung cancer.
    D'Cunha J
    Semin Thorac Cardiovasc Surg; 2010; 22(2):118-20. PubMed ID: 21092888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalizing medicine: strategies for implementing the evaluation of anaplastic lymphoma kinase rearrangement in non-small-cell lung cancer in Portugal.
    Araújo A; Coelho A; de Mello RA; Azevedo I; Soares M; Queiroga H; Teixeira E; Parente B; Barata F
    Rev Port Pneumol; 2012; 18(5):244-6. PubMed ID: 22748945
    [No Abstract]   [Full Text] [Related]  

  • 10. Assessing prognosis in non-small-cell lung cancer: avenues to a more complete picture?
    Dubinett SM; Elashoff D; Meyerson M
    J Clin Oncol; 2004 Aug; 22(16):3209-11. PubMed ID: 15249586
    [No Abstract]   [Full Text] [Related]  

  • 11. Personalized medicine for lung cancer: new challenges for pathology.
    Kerr KM
    Histopathology; 2012 Mar; 60(4):531-46. PubMed ID: 21916947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospects for molecular staging of non-small-cell lung cancer from genomic alterations.
    Tomaszek SC; Huebner M; Wigle DA
    Expert Rev Respir Med; 2010 Aug; 4(4):499-508. PubMed ID: 20658911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The clinical significance of biological characters on non-small cell lung cancer].
    Liao M; Lin Z; Zhou Y
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Jan; 21(1):30-3. PubMed ID: 11263297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [EML4-ALK fusion in non-small-cell lung cancer].
    Wang X; Bai CX
    Zhonghua Jie He He Hu Xi Za Zhi; 2011 Mar; 34(3):207-9. PubMed ID: 21569690
    [No Abstract]   [Full Text] [Related]  

  • 15. Evaluation and treatment of patients with non-small cell lung cancer.
    Carr LL; Finigan JH; Kern JA
    Med Clin North Am; 2011 Nov; 95(6):1041-54. PubMed ID: 22032426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Management of non small cell lung cancer].
    Ourari-Dhahri B; Ben Slima H; Ben Amar J; El Gharbi L; Ali M; Baccar Azzabi S; Aouina H; Bouacha H
    Tunis Med; 2012 Dec; 90(12):847-51. PubMed ID: 23247782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lung cancer - genomics and personalized medicine.
    Mahapatra A
    ACS Chem Biol; 2010 Jun; 5(6):529-31. PubMed ID: 20557136
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic advances in non-small cell lung cancer.
    Vallières E; Peters S; Van Houtte P; Dalal P; Lim E
    Thorax; 2012 Dec; 67(12):1097-101. PubMed ID: 22058187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment based on biological characteristics of lung cancer: biological differences between small cell and non-small cell lung cancer and gene therapy].
    Tanio Y
    Gan To Kagaku Ryoho; 1997 Oct; 24 Suppl 3():337-44. PubMed ID: 9369905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-small cell lung cancer.
    Ettinger DS; Akerley W; Bepler G; Blum MG; Chang A; Cheney RT; Chirieac LR; D'Amico TA; Demmy TL; Ganti AK; Govindan R; Grannis FW; Jahan T; Jahanzeb M; Johnson DH; Kessinger A; Komaki R; Kong FM; Kris MG; Krug LM; Le QT; Lennes IT; Martins R; O'Malley J; Osarogiagbon RU; Otterson GA; Patel JD; Pisters KM; Reckamp K; Riely GJ; Rohren E; Simon GR; Swanson SJ; Wood DE; Yang SC;
    J Natl Compr Canc Netw; 2010 Jul; 8(7):740-801. PubMed ID: 20679538
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.